MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnostics has created a Histoplasma Urine Antigen LFA.
MiraVista Diagnostics is leading the industry with a new Histoplama Urine Antigen LFA. The rapid, non-invasive test demonstrates 96% correlation with the MiraVista Histoplasma Antigen Quantitative EIA, can be operated in low complexity clinical settings and requires no additional materials or equipment.
